Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
EGFR signaling in breast cancer: Bad to the bone
HTML
Details
Locations
Year:
2010
Type:
review
Source:
Seminars in Cell and Developmental Biology
DOI:
10.1016/j.semcdb.2010.08.009
Authors:
John Foley,
Nicole K. Nickerson,
Seungyoon Nam,
Kah Tan Allen,
Jennifer L. Gilmore,
Kenneth P. Nephew,
David J. Riese
show all 7
Institutions:
Indiana University Bloomington,
Indiana University Indianapolis,
Indiana University Melvin and Bren Simon Comprehensive Cancer Center,
Indiana University School of Medicine,
Indiana University,
Purdue University West Lafayette
show all 6
Language:
English
Topic:
HER2/EGFR in Cancer Research
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
green
Funders:
U.S. Department of Defense,
Susan G. Komen,
Purdue University Center for Cancer Research,
National Institutes of Health,
National Cancer Institute
Awards:
Regulation of ErbB4 Signaling by Neuregulin Isoforms,
Interrogating Epigenetic Changes in Cancer Genomes,
Cancer Center Support Grant
OpenAlex ID:
W2060099765
FWCI:
1.597
Cites:
132
Cited by:
152
Related to:
10